Maximum standard uptake value of 18F-fluorodeoxyglucose positron emission tomography is a prognostic factor for progression-free survival of newly diagnosed patients ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2013-02

AUTHORS

Yukihiro Miyazaki, Yuichiro Nawa, Masao Miyagawa, Sumiko Kohashi, Koichi Nakase, Masaki Yasukawa, Masamichi Hara

ABSTRACT

The treatment of patients with diffuse large B cell lymphoma (DLBCL) would be greatly facilitated with a rapid method for determining prognosis that can be performed more easily and earlier than cytological or specific pathological examinations. It has been suggested that newly diagnosed patients with DLBCL who have low maximum standard uptake value (SUV(max)) on (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) are more likely to be successfully treated and remain in remission compared with patients with high SUV(max), but this concept has been poorly studied. We retrospectively analyzed 50 patients with de novo DLBCL to evaluate the relationship between the SUV(max) and disease progression. For patients with low SUV(max) (n = 10) and high SUV(max) (n = 40) (P = 0.255), respectively, the 3-year overall survival rates were 90 and 72 %, and the progression-free survival (PFS) rates were 90 and 39 % (P = 0.012). By multivariate analysis, the revised International Prognostics Index (R-IPI) and SUV(max) at diagnosis were shown to predict longer PFS. The 3-year PFS for patients with low SUV(max) classified into the good prognosis group by R-IPI was 100 vs. 62 % for those with high SUV(max) (P = 0.161), and patients with low SUV(max) classified into the poor prognosis group by R-IPI was 80 vs. 18 % for those with high SUV(max) (P = 0.050). We conclude that the SUV(max) on FDG-PET for newly diagnosed patients with DLBCL is an important predictor of disease progression, especially for patients with poor prognosis by R-IPI. More... »

PAGES

239-244

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00277-012-1602-3

DOI

http://dx.doi.org/10.1007/s00277-012-1602-3

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1016010275

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/23079891


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Age Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal, Murine-Derived", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Combined Modality Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cyclophosphamide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease-Free Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Doxorubicin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluorine Radioisotopes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluorodeoxyglucose F18", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hematopoietic Stem Cell Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kaplan-Meier Estimate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphoma, Large B-Cell, Diffuse", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Patient Selection", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Positron-Emission Tomography", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prednisolone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proportional Hazards Models", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radiopharmaceuticals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rituximab", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vincristine", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Ehime Prefectural Central Hospital", 
          "id": "https://www.grid.ac/institutes/grid.414413.7", 
          "name": [
            "Department of Bioregulatory Medicine, Ehime University Graduate School of Medicine, Shitsukawa, 791-0295, Toon, Ehime, Japan", 
            "Division of Hematology, Ehime Prefectural Central Hospital, Matsuyama, Ehime, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Miyazaki", 
        "givenName": "Yukihiro", 
        "id": "sg:person.01002012476.64", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01002012476.64"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ehime Prefectural Central Hospital", 
          "id": "https://www.grid.ac/institutes/grid.414413.7", 
          "name": [
            "Division of Hematology, Ehime Prefectural Central Hospital, Matsuyama, Ehime, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nawa", 
        "givenName": "Yuichiro", 
        "id": "sg:person.01235232263.62", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01235232263.62"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ehime Prefectural Central Hospital", 
          "id": "https://www.grid.ac/institutes/grid.414413.7", 
          "name": [
            "Division of Radiology, Ehime Prefectural Central Hospital, Matsuyama, Ehime, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Miyagawa", 
        "givenName": "Masao", 
        "id": "sg:person.01076114534.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01076114534.40"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ehime Prefectural Central Hospital", 
          "id": "https://www.grid.ac/institutes/grid.414413.7", 
          "name": [
            "Division of Hematology, Ehime Prefectural Central Hospital, Matsuyama, Ehime, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kohashi", 
        "givenName": "Sumiko", 
        "id": "sg:person.01070340147.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01070340147.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ehime Prefectural Central Hospital", 
          "id": "https://www.grid.ac/institutes/grid.414413.7", 
          "name": [
            "Division of Hematology, Ehime Prefectural Central Hospital, Matsuyama, Ehime, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nakase", 
        "givenName": "Koichi", 
        "id": "sg:person.01174736411.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174736411.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ehime University", 
          "id": "https://www.grid.ac/institutes/grid.255464.4", 
          "name": [
            "Department of Bioregulatory Medicine, Ehime University Graduate School of Medicine, Shitsukawa, 791-0295, Toon, Ehime, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yasukawa", 
        "givenName": "Masaki", 
        "id": "sg:person.0730073225.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0730073225.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ehime Prefectural Central Hospital", 
          "id": "https://www.grid.ac/institutes/grid.414413.7", 
          "name": [
            "Division of Hematology, Ehime Prefectural Central Hospital, Matsuyama, Ehime, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hara", 
        "givenName": "Masamichi", 
        "id": "sg:person.0702377030.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0702377030.82"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1093/annonc/mdn392", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002958217"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12185-011-0822-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004034909", 
          "https://doi.org/10.1007/s12185-011-0822-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12185-011-0822-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004034909", 
          "https://doi.org/10.1007/s12185-011-0822-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1600-0609.2010.01467.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006085010"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199309303291402", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013554742"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ctrv.2007.02.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020576240"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2006.08.2305", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020848737"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(11)70235-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021792870"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2003-06-2095", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022035062"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/10428190903440953", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024334269"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2003-05-1545", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026049587"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood.v99.3.815", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027088442"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2010-03-276246", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031111650"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2006-08-038257", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036676724"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2006.09.2403", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045509899"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(08)70002-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047262140"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199512073332305", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048188294"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2010.28.1618", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049306116"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2007-06-097238", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050417265"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2008-06-155820", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050529744"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2000.18.16.3025", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074684756"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2013-02", 
    "datePublishedReg": "2013-02-01", 
    "description": "The treatment of patients with diffuse large B cell lymphoma (DLBCL) would be greatly facilitated with a rapid method for determining prognosis that can be performed more easily and earlier than cytological or specific pathological examinations. It has been suggested that newly diagnosed patients with DLBCL who have low maximum standard uptake value (SUV(max)) on (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) are more likely to be successfully treated and remain in remission compared with patients with high SUV(max), but this concept has been poorly studied. We retrospectively analyzed 50 patients with de novo DLBCL to evaluate the relationship between the SUV(max) and disease progression. For patients with low SUV(max) (n\u2009=\u200910) and high SUV(max) (n\u2009=\u200940) (P\u2009=\u20090.255), respectively, the 3-year overall survival rates were 90 and 72\u00a0%, and the progression-free survival (PFS) rates were 90 and 39\u00a0% (P\u2009=\u20090.012). By multivariate analysis, the revised International Prognostics Index (R-IPI) and SUV(max) at diagnosis were shown to predict longer PFS. The 3-year PFS for patients with low SUV(max) classified into the good prognosis group by R-IPI was 100 vs. 62\u00a0% for those with high SUV(max) (P\u2009=\u20090.161), and patients with low SUV(max) classified into the poor prognosis group by R-IPI was 80 vs. 18\u00a0% for those with high SUV(max) (P\u2009=\u20090.050). We conclude that the SUV(max) on FDG-PET for newly diagnosed patients with DLBCL is an important predictor of disease progression, especially for patients with poor prognosis by R-IPI.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00277-012-1602-3", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1018247", 
        "issn": [
          "1269-3286", 
          "1279-8509"
        ], 
        "name": "Annals of Hematology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "92"
      }
    ], 
    "name": "Maximum standard uptake value of 18F-fluorodeoxyglucose positron emission tomography is a prognostic factor for progression-free survival of newly diagnosed patients with diffuse large B cell lymphoma", 
    "pagination": "239-244", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "4c4919d5ae29fa07f5de7f2edb167c549eea3316563238abc4e9c3cc55d5f008"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "23079891"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9107334"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00277-012-1602-3"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1016010275"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00277-012-1602-3", 
      "https://app.dimensions.ai/details/publication/pub.1016010275"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T14:54", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8663_00000487.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/s00277-012-1602-3"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00277-012-1602-3'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00277-012-1602-3'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00277-012-1602-3'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00277-012-1602-3'


 

This table displays all metadata directly associated to this object as RDF triples.

293 TRIPLES      21 PREDICATES      78 URIs      50 LITERALS      38 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00277-012-1602-3 schema:about N0a734a9d18d74f0cae90bdabf1495672
2 N0f86f98384f34ae2ac97acf419a26ea8
3 N275e58fe95054e418385dfc67375f0c7
4 N2b14bebab8304dfd9386964aaaea7aac
5 N320e63d5a22f4dba87cddf66cec79bc8
6 N3aa924c6411b489eb6c1a06847613142
7 N40609247edf84b7eb9a35df61e7d5434
8 N51df1dbda4d74be38c7d3a0f8087f1c4
9 N58d1b72a424e4c58b521a18fdb406229
10 N67e03e5be83848289feea159b1900e79
11 N68988d61bcb948fabbefac87495a5e6f
12 N6a3415b321a94ec8ae42b91595ca27f4
13 N7968a9c53d3a40739a64592dd9809909
14 N7a1a9728609b4edd8024b7f605f9289e
15 N805d2a20383f4d5aa6226714d9345019
16 N86a3672d82ff413c8f14213b3a8d94aa
17 N926a464d5412493b8aeeaef1d7df7695
18 N9543866a8edb455fb1fb7d281fa7c1e6
19 Na8bf51d00f7048b186da857e07c91183
20 Na8dabd6ad4c64c62bcb3b8935289597c
21 Nb39e97e01da24011af2a7246c9db500b
22 Nb852d68ce9874e8ea714aa17fcee0d89
23 Nbc9a4d927c8f41859b3e2ed39e9e37ab
24 Nbe553efe4e5c41b992e48f3e85c1ea80
25 Nc2f68b9e35cd4fd5ae9429310ac66975
26 Ncb8a00fe197b4f0a80fa41a45cddaf0a
27 Ndd9edbd9d6d34f46820214c9587001cd
28 Ne1da3e55491344cdb82056097d16ea79
29 Neca09e972e2f4da0bafa3b68c0b228f1
30 anzsrc-for:11
31 anzsrc-for:1103
32 schema:author N077e7bd5b605441587c5e1a14c36f574
33 schema:citation sg:pub.10.1007/s12185-011-0822-y
34 https://doi.org/10.1016/j.ctrv.2007.02.002
35 https://doi.org/10.1016/s1470-2045(08)70002-0
36 https://doi.org/10.1016/s1470-2045(11)70235-2
37 https://doi.org/10.1056/nejm199309303291402
38 https://doi.org/10.1056/nejm199512073332305
39 https://doi.org/10.1093/annonc/mdn392
40 https://doi.org/10.1111/j.1600-0609.2010.01467.x
41 https://doi.org/10.1182/blood-2003-05-1545
42 https://doi.org/10.1182/blood-2003-06-2095
43 https://doi.org/10.1182/blood-2006-08-038257
44 https://doi.org/10.1182/blood-2007-06-097238
45 https://doi.org/10.1182/blood-2008-06-155820
46 https://doi.org/10.1182/blood-2010-03-276246
47 https://doi.org/10.1182/blood.v99.3.815
48 https://doi.org/10.1200/jco.2000.18.16.3025
49 https://doi.org/10.1200/jco.2006.08.2305
50 https://doi.org/10.1200/jco.2006.09.2403
51 https://doi.org/10.1200/jco.2010.28.1618
52 https://doi.org/10.3109/10428190903440953
53 schema:datePublished 2013-02
54 schema:datePublishedReg 2013-02-01
55 schema:description The treatment of patients with diffuse large B cell lymphoma (DLBCL) would be greatly facilitated with a rapid method for determining prognosis that can be performed more easily and earlier than cytological or specific pathological examinations. It has been suggested that newly diagnosed patients with DLBCL who have low maximum standard uptake value (SUV(max)) on (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) are more likely to be successfully treated and remain in remission compared with patients with high SUV(max), but this concept has been poorly studied. We retrospectively analyzed 50 patients with de novo DLBCL to evaluate the relationship between the SUV(max) and disease progression. For patients with low SUV(max) (n = 10) and high SUV(max) (n = 40) (P = 0.255), respectively, the 3-year overall survival rates were 90 and 72 %, and the progression-free survival (PFS) rates were 90 and 39 % (P = 0.012). By multivariate analysis, the revised International Prognostics Index (R-IPI) and SUV(max) at diagnosis were shown to predict longer PFS. The 3-year PFS for patients with low SUV(max) classified into the good prognosis group by R-IPI was 100 vs. 62 % for those with high SUV(max) (P = 0.161), and patients with low SUV(max) classified into the poor prognosis group by R-IPI was 80 vs. 18 % for those with high SUV(max) (P = 0.050). We conclude that the SUV(max) on FDG-PET for newly diagnosed patients with DLBCL is an important predictor of disease progression, especially for patients with poor prognosis by R-IPI.
56 schema:genre research_article
57 schema:inLanguage en
58 schema:isAccessibleForFree true
59 schema:isPartOf N65cf0537eb154014a6a0ed02944f6b56
60 Nca0d65d2cc3c4ed38ed69c80ed319854
61 sg:journal.1018247
62 schema:name Maximum standard uptake value of 18F-fluorodeoxyglucose positron emission tomography is a prognostic factor for progression-free survival of newly diagnosed patients with diffuse large B cell lymphoma
63 schema:pagination 239-244
64 schema:productId N5835fc7ef9b748eabd9e0bff90b762ce
65 N790f2a033d5843bb9562f844858a3d6d
66 N7b622a59e1004c5488d6086c43bf4939
67 Ne91a2fd63bf84ca69828173577499bdc
68 Nfbb773acd83a4f958c9d4c1b57112b08
69 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016010275
70 https://doi.org/10.1007/s00277-012-1602-3
71 schema:sdDatePublished 2019-04-10T14:54
72 schema:sdLicense https://scigraph.springernature.com/explorer/license/
73 schema:sdPublisher N7a0bc7560cc6441189e3c90048844776
74 schema:url http://link.springer.com/10.1007/s00277-012-1602-3
75 sgo:license sg:explorer/license/
76 sgo:sdDataset articles
77 rdf:type schema:ScholarlyArticle
78 N077e7bd5b605441587c5e1a14c36f574 rdf:first sg:person.01002012476.64
79 rdf:rest Nbc0eb6bb5bbf46958871d7323501747e
80 N0a734a9d18d74f0cae90bdabf1495672 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Humans
82 rdf:type schema:DefinedTerm
83 N0f86f98384f34ae2ac97acf419a26ea8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Proportional Hazards Models
85 rdf:type schema:DefinedTerm
86 N275e58fe95054e418385dfc67375f0c7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Combined Modality Therapy
88 rdf:type schema:DefinedTerm
89 N2b14bebab8304dfd9386964aaaea7aac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Antineoplastic Combined Chemotherapy Protocols
91 rdf:type schema:DefinedTerm
92 N320e63d5a22f4dba87cddf66cec79bc8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Fluorodeoxyglucose F18
94 rdf:type schema:DefinedTerm
95 N3aa924c6411b489eb6c1a06847613142 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Doxorubicin
97 rdf:type schema:DefinedTerm
98 N40609247edf84b7eb9a35df61e7d5434 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Treatment Outcome
100 rdf:type schema:DefinedTerm
101 N51df1dbda4d74be38c7d3a0f8087f1c4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Rituximab
103 rdf:type schema:DefinedTerm
104 N5835fc7ef9b748eabd9e0bff90b762ce schema:name dimensions_id
105 schema:value pub.1016010275
106 rdf:type schema:PropertyValue
107 N58d1b72a424e4c58b521a18fdb406229 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Female
109 rdf:type schema:DefinedTerm
110 N65cf0537eb154014a6a0ed02944f6b56 schema:issueNumber 2
111 rdf:type schema:PublicationIssue
112 N67e03e5be83848289feea159b1900e79 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Positron-Emission Tomography
114 rdf:type schema:DefinedTerm
115 N68988d61bcb948fabbefac87495a5e6f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Prognosis
117 rdf:type schema:DefinedTerm
118 N6a3415b321a94ec8ae42b91595ca27f4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Hematopoietic Stem Cell Transplantation
120 rdf:type schema:DefinedTerm
121 N790f2a033d5843bb9562f844858a3d6d schema:name doi
122 schema:value 10.1007/s00277-012-1602-3
123 rdf:type schema:PropertyValue
124 N7968a9c53d3a40739a64592dd9809909 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Prednisolone
126 rdf:type schema:DefinedTerm
127 N7a0bc7560cc6441189e3c90048844776 schema:name Springer Nature - SN SciGraph project
128 rdf:type schema:Organization
129 N7a1a9728609b4edd8024b7f605f9289e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Fluorine Radioisotopes
131 rdf:type schema:DefinedTerm
132 N7b622a59e1004c5488d6086c43bf4939 schema:name nlm_unique_id
133 schema:value 9107334
134 rdf:type schema:PropertyValue
135 N7cbed02d14594e078ae5b221c89986ad rdf:first sg:person.01174736411.20
136 rdf:rest Nf9eeee37ab2e43e9acc996cad196e6df
137 N805d2a20383f4d5aa6226714d9345019 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Radiopharmaceuticals
139 rdf:type schema:DefinedTerm
140 N86a3672d82ff413c8f14213b3a8d94aa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Age Factors
142 rdf:type schema:DefinedTerm
143 N926a464d5412493b8aeeaef1d7df7695 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Disease-Free Survival
145 rdf:type schema:DefinedTerm
146 N9543866a8edb455fb1fb7d281fa7c1e6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Antibodies, Monoclonal, Murine-Derived
148 rdf:type schema:DefinedTerm
149 Na8bf51d00f7048b186da857e07c91183 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Vincristine
151 rdf:type schema:DefinedTerm
152 Na8dabd6ad4c64c62bcb3b8935289597c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Aged
154 rdf:type schema:DefinedTerm
155 Naf8da8e784fe4af39cebe43c1f8f4b67 rdf:first sg:person.0702377030.82
156 rdf:rest rdf:nil
157 Nb1094bc8789b4bd4953a787f471f13ca rdf:first sg:person.01076114534.40
158 rdf:rest Nd5c866d081004777a865431c8fdf1878
159 Nb39e97e01da24011af2a7246c9db500b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Cyclophosphamide
161 rdf:type schema:DefinedTerm
162 Nb852d68ce9874e8ea714aa17fcee0d89 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Middle Aged
164 rdf:type schema:DefinedTerm
165 Nbc0eb6bb5bbf46958871d7323501747e rdf:first sg:person.01235232263.62
166 rdf:rest Nb1094bc8789b4bd4953a787f471f13ca
167 Nbc9a4d927c8f41859b3e2ed39e9e37ab schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Adult
169 rdf:type schema:DefinedTerm
170 Nbe553efe4e5c41b992e48f3e85c1ea80 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Patient Selection
172 rdf:type schema:DefinedTerm
173 Nc2f68b9e35cd4fd5ae9429310ac66975 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Kaplan-Meier Estimate
175 rdf:type schema:DefinedTerm
176 Nca0d65d2cc3c4ed38ed69c80ed319854 schema:volumeNumber 92
177 rdf:type schema:PublicationVolume
178 Ncb8a00fe197b4f0a80fa41a45cddaf0a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Male
180 rdf:type schema:DefinedTerm
181 Nd5c866d081004777a865431c8fdf1878 rdf:first sg:person.01070340147.42
182 rdf:rest N7cbed02d14594e078ae5b221c89986ad
183 Ndd9edbd9d6d34f46820214c9587001cd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
184 schema:name Retrospective Studies
185 rdf:type schema:DefinedTerm
186 Ne1da3e55491344cdb82056097d16ea79 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name Aged, 80 and over
188 rdf:type schema:DefinedTerm
189 Ne91a2fd63bf84ca69828173577499bdc schema:name readcube_id
190 schema:value 4c4919d5ae29fa07f5de7f2edb167c549eea3316563238abc4e9c3cc55d5f008
191 rdf:type schema:PropertyValue
192 Neca09e972e2f4da0bafa3b68c0b228f1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
193 schema:name Lymphoma, Large B-Cell, Diffuse
194 rdf:type schema:DefinedTerm
195 Nf9eeee37ab2e43e9acc996cad196e6df rdf:first sg:person.0730073225.12
196 rdf:rest Naf8da8e784fe4af39cebe43c1f8f4b67
197 Nfbb773acd83a4f958c9d4c1b57112b08 schema:name pubmed_id
198 schema:value 23079891
199 rdf:type schema:PropertyValue
200 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
201 schema:name Medical and Health Sciences
202 rdf:type schema:DefinedTerm
203 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
204 schema:name Clinical Sciences
205 rdf:type schema:DefinedTerm
206 sg:journal.1018247 schema:issn 1269-3286
207 1279-8509
208 schema:name Annals of Hematology
209 rdf:type schema:Periodical
210 sg:person.01002012476.64 schema:affiliation https://www.grid.ac/institutes/grid.414413.7
211 schema:familyName Miyazaki
212 schema:givenName Yukihiro
213 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01002012476.64
214 rdf:type schema:Person
215 sg:person.01070340147.42 schema:affiliation https://www.grid.ac/institutes/grid.414413.7
216 schema:familyName Kohashi
217 schema:givenName Sumiko
218 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01070340147.42
219 rdf:type schema:Person
220 sg:person.01076114534.40 schema:affiliation https://www.grid.ac/institutes/grid.414413.7
221 schema:familyName Miyagawa
222 schema:givenName Masao
223 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01076114534.40
224 rdf:type schema:Person
225 sg:person.01174736411.20 schema:affiliation https://www.grid.ac/institutes/grid.414413.7
226 schema:familyName Nakase
227 schema:givenName Koichi
228 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174736411.20
229 rdf:type schema:Person
230 sg:person.01235232263.62 schema:affiliation https://www.grid.ac/institutes/grid.414413.7
231 schema:familyName Nawa
232 schema:givenName Yuichiro
233 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01235232263.62
234 rdf:type schema:Person
235 sg:person.0702377030.82 schema:affiliation https://www.grid.ac/institutes/grid.414413.7
236 schema:familyName Hara
237 schema:givenName Masamichi
238 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0702377030.82
239 rdf:type schema:Person
240 sg:person.0730073225.12 schema:affiliation https://www.grid.ac/institutes/grid.255464.4
241 schema:familyName Yasukawa
242 schema:givenName Masaki
243 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0730073225.12
244 rdf:type schema:Person
245 sg:pub.10.1007/s12185-011-0822-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1004034909
246 https://doi.org/10.1007/s12185-011-0822-y
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1016/j.ctrv.2007.02.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020576240
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1016/s1470-2045(08)70002-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047262140
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1016/s1470-2045(11)70235-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021792870
253 rdf:type schema:CreativeWork
254 https://doi.org/10.1056/nejm199309303291402 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013554742
255 rdf:type schema:CreativeWork
256 https://doi.org/10.1056/nejm199512073332305 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048188294
257 rdf:type schema:CreativeWork
258 https://doi.org/10.1093/annonc/mdn392 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002958217
259 rdf:type schema:CreativeWork
260 https://doi.org/10.1111/j.1600-0609.2010.01467.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1006085010
261 rdf:type schema:CreativeWork
262 https://doi.org/10.1182/blood-2003-05-1545 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026049587
263 rdf:type schema:CreativeWork
264 https://doi.org/10.1182/blood-2003-06-2095 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022035062
265 rdf:type schema:CreativeWork
266 https://doi.org/10.1182/blood-2006-08-038257 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036676724
267 rdf:type schema:CreativeWork
268 https://doi.org/10.1182/blood-2007-06-097238 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050417265
269 rdf:type schema:CreativeWork
270 https://doi.org/10.1182/blood-2008-06-155820 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050529744
271 rdf:type schema:CreativeWork
272 https://doi.org/10.1182/blood-2010-03-276246 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031111650
273 rdf:type schema:CreativeWork
274 https://doi.org/10.1182/blood.v99.3.815 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027088442
275 rdf:type schema:CreativeWork
276 https://doi.org/10.1200/jco.2000.18.16.3025 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074684756
277 rdf:type schema:CreativeWork
278 https://doi.org/10.1200/jco.2006.08.2305 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020848737
279 rdf:type schema:CreativeWork
280 https://doi.org/10.1200/jco.2006.09.2403 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045509899
281 rdf:type schema:CreativeWork
282 https://doi.org/10.1200/jco.2010.28.1618 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049306116
283 rdf:type schema:CreativeWork
284 https://doi.org/10.3109/10428190903440953 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024334269
285 rdf:type schema:CreativeWork
286 https://www.grid.ac/institutes/grid.255464.4 schema:alternateName Ehime University
287 schema:name Department of Bioregulatory Medicine, Ehime University Graduate School of Medicine, Shitsukawa, 791-0295, Toon, Ehime, Japan
288 rdf:type schema:Organization
289 https://www.grid.ac/institutes/grid.414413.7 schema:alternateName Ehime Prefectural Central Hospital
290 schema:name Department of Bioregulatory Medicine, Ehime University Graduate School of Medicine, Shitsukawa, 791-0295, Toon, Ehime, Japan
291 Division of Hematology, Ehime Prefectural Central Hospital, Matsuyama, Ehime, Japan
292 Division of Radiology, Ehime Prefectural Central Hospital, Matsuyama, Ehime, Japan
293 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...